GlaxoSmithKline
3 stories related to this topic, newest first.
medpagetoday.comRecent Developments in CAR-T Therapy for Autoimmunity and GSK's Discontinuation of Leucovorin
Researchers are exploring CAR-T cell therapy's potential in treating autoimmune diseases beyond cancer. GlaxoSmithKline announced it will discontinue leucovorin, a drug used in chemotherapy support. These updates highlight ongoing advancements and changes in the biotechnology sec…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)FDA Withdraws Approval of GSK Drug; GLP-1 Generics Enter India Market; Estrogen Patches Face Shortage
The U.S. Food and Drug Administration withdrew approval for a GlaxoSmithKline drug previously promoted by the Trump administration for autism treatment. In India, generic versions of GLP-1 drugs are entering the obesity treatment market. A shortage of estrogen patches used for me…
Maxwell Hamilton / Wikimedia (CC BY-SA 3.0)FDA Withdraws Approval for GSK's Leucovorin in Treating Cerebral Folate Deficiency
The U.S. Food and Drug Administration is withdrawing approval for GlaxoSmithKline's leucovorin as a treatment for cerebral folate deficiency, a rare brain disorder. GSK stated that the withdrawal was anticipated as part of the original approval plan. The disorder involves symptom…